News Releases

Leading Intellectual Property Counsel, James Kellerman, Joins Astellas as Vice President

NORTHBROOK, Ill., Sept. 2, 2014 /PRNewswire/ -- Astellas has appointed James Kellerman as the vice president of intellectual property (IP) in the Americas. Kellerman will report directly to Linda Friedman, senior vice president & general counsel at Astellas. In his new role, Kellerman will lead a team of patent attorneys to partner with the business and manage the region's intellectual property matters, coordinating closely with his global colleagues.

Leading Intellectual Property Counsel, James Kellerman, Joins Astellas as Vice President

"I am very pleased to welcome Jim to Astellas. Jim brings a broad perspective of the industry and a breadth of pharmaceutical IP experience to his new position. He will be a strong leader for our IP group," said Friedman.

Kellerman has more than 25 years of broad IP and industry experience in the pharmaceutical industry as well as experience in other roles early in his career. For the past 11 years, Kellerman has worked at GlaxoSmithKline in the IP department in the US as well as in China. Prior to that he was the corporate intellectual property counsel for Sepracor Inc. Kellerman received his B.S. Pharmacy from the University of Cincinnati, College of Pharmacy and his law degree from the Franklin Pierce Law Center in Concord, New Hampshire.

About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS.

Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

Photo - http://photos.prnewswire.com/prnh/20140902/142153
Logo - http://photos.prnewswire.com/prnh/20140416/84970

SOURCE Astellas

For further information: Jenny Kite, 224-205-5405, jenny.kite@astellas.com
Stay Connected

Get only the email alerts you want.

Subscribe

Media Contacts

 

For media inquiries and reporter requests, please click here to fill out a request form.

Our communications team will respond to verified media requests within 24-48 hours as appropriate.

If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.

 

Astellas on Twitter
Download Fact Sheet
Sustainability
Investors
Explore U.S. Products